THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

R Squared Ltd's Holding History (CIK: 0001896148)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 15,737 Value ($000) $294 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 19,621 Value ($000) $286 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 19,976 Value ($000) $220 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 12,522 Value ($000) $112 Avg Close $9.31 Range $8.35 - $10.90

Q4 2024

Shares 1,700 Value ($000) $16 Avg Close $9.10 Range $7.88 - $10.26

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	15,737	$294	$16.59	$13.50 - $20.33
Q3 2025	19,621	$286	$12.64	$10.82 - $14.87
Q2 2025	19,976	$220	$9.72	$7.90 - $11.82
Q1 2025	12,522	$112	$9.31	$8.35 - $10.90
Q4 2024	1,700	$16	$9.10	$7.88 - $10.26